Investor Relations

RSS Content

Vanda Pharmaceuticals Announces Participation at November 2017 Investor Conferences

WASHINGTON, Nov. 13, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in November 2017.

The Stifel 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017. A corporate presentation is scheduled for 11:45 a.m. Eastern Time.

The Jefferies 2017 London Healthcare Conference in London, England on November 15-16, 2017. A corporate presentation is scheduled for Wednesday, November 15, 2017 at 11:20 a.m. Greenwich Mean Time (6:20 a.m. Eastern Time).

The 29th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, November 29, 2017. A corporate presentation is scheduled for 3:00 p.m. Eastern Time.

The corporate presentations given at the Stifel, Jefferies and Piper conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428

View original content:

SOURCE Vanda Pharmaceuticals Inc.

Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy